Connection

Deirdre Luttrell to Mice

This is a "connection" page, showing publications Deirdre Luttrell has written about Mice.
Connection Strength

0.051
  1. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol. 2013; 522:229-62.
    View in: PubMed
    Score: 0.011
  2. Overexpression of pp60c-src is associated with altered regulation of adenylyl cyclase. Cell Signal. 1992 Sep; 4(5):531-41.
    View in: PubMed
    Score: 0.011
  3. Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. J Med Chem. 2008 Aug 14; 51(15):4632-40.
    View in: PubMed
    Score: 0.008
  4. Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Mol Cancer Ther. 2007 Jul; 6(7):2012-21.
    View in: PubMed
    Score: 0.008
  5. Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10; 48(5):1610-9.
    View in: PubMed
    Score: 0.007
  6. Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models. Br J Cancer. 2004 Oct 04; 91(7):1391-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.